Weight loss, diabetes drugs propel Eli Lilly to largely better-than-expected forecast for 2024
The popular diabetes treatment Mounjaro pushed Eli Lilly past fourth-quarter forecasts, and the drugmaker predicted that 2024 will turn out largely better than expected too as new products build momentum. …